Skip to main content
. 2018 Jan 22;9(2):68. doi: 10.1038/s41419-017-0075-7

Fig. 2. Niclosamide inhibits the downstream molecules of BCR-ABL.

Fig. 2

CML cells were treated with increasing concentrations of niclosamide for 48 h (a) or a fixed concentration for different durations (b) and subjected to Western blotting analysis. Actin served as a loading control for blots above, which were performed sequentially